6-5404635-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006567.5(FARS2):c.706G>A(p.Val236Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,612,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006567.5 missense
Scores
Clinical Significance
Conservation
Publications
- metabolic diseaseInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- combined oxidative phosphorylation defect type 14Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary spastic paraplegia 77Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| FARS2 | ENST00000274680.9 | c.706G>A | p.Val236Met | missense_variant | Exon 3 of 7 | 1 | NM_006567.5 | ENSP00000274680.4 | ||
| FARS2 | ENST00000324331.10 | c.706G>A | p.Val236Met | missense_variant | Exon 3 of 7 | 1 | ENSP00000316335.5 | |||
| FARS2 | ENST00000445533.1 | c.94G>A | p.Val32Met | missense_variant | Exon 1 of 3 | 3 | ENSP00000392525.1 | |||
| FARS2 | ENST00000648580.1 | n.706G>A | non_coding_transcript_exon_variant | Exon 3 of 9 | ENSP00000497889.1 | 
Frequencies
GnomAD3 genomes  0.0000263  AC: 4AN: 152192Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000319  AC: 8AN: 250692 AF XY:  0.0000369   show subpopulations 
GnomAD4 exome  AF:  0.0000431  AC: 63AN: 1460370Hom.:  0  Cov.: 31 AF XY:  0.0000427  AC XY: 31AN XY: 726402 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000263  AC: 4AN: 152192Hom.:  0  Cov.: 32 AF XY:  0.0000269  AC XY: 2AN XY: 74362 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 14    Uncertain:2 
This sequence change replaces valine with methionine at codon 236 of the FARS2 protein (p.Val236Met). The valine residue is moderately conserved and there is a small physicochemical difference between valine and methionine. This variant is present in population databases (rs369015058, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with FARS2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at